Kai Hilpert
Impact in
- Microbiology top 0.02%
- Antimicrobial Peptides and Activities
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Biochemical and Structural Characterization 26
- Chemical Synthesis and Analysis 15
- Protein Hydrolysis and Bioactive Peptides 7
- Microbiology 48
- Antimicrobial Peptides and Activities 48
- Co-authors
- Robert E. W. Hancock (19 shared papers)Irith Wiegand (1 shared paper)Rudolf Volkmer (9 shared papers)Dirk Winkler (6 shared papers)Håvard Jenssen (8 shared papers)Christopher D. Fjell (7 shared papers)Artem Cherkasov (6 shared papers)Ralf Mikut (16 shared papers)
- Journals
- Biochimica et Biophysica Acta (BBA) - Biomembranes (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)Frontiers in Pharmacology (4 papers)Nature Protocols (3 papers)Frontiers in Microbiology (3 papers)
- Partner nations
- GermanyUnited KingdomCanada
In The Last Decade
Kai Hilpert
71 papers receiving 8.2k citations
Kai Hilpert's Hit Papers
Peers
Comparison fields: 5 of 160
- Microbiology 3.8k
- Molecular Medicine 904
- Molecular Biology 4.3k
- Food Science 1.1k
- Organic Chemistry 1.5k
Countries citing papers authored by Kai Hilpert
This map shows the geographic impact of Kai Hilpert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Hilpert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Hilpert more than expected).
Fields of papers citing papers by Kai Hilpert
This network shows the impact of papers produced by Kai Hilpert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Hilpert. The network helps show where Kai Hilpert may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Hilpert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances Hit paper breakdown → | 2008 | 4683 |
| 2 | 2005 | 325 | |
| 3 | 2011 | 311 | |
| 4 | 2008 | 307 | |
| 5 | 2009 | 232 | |
| 6 | 2007 | 225 | |
| 7 | 2009 | 192 | |
| 8 | 2009 | 180 | |
| 9 | 2006 | 146 | |
| 10 | 2010 | 139 | |
| 11 | 2018 | 109 | |
| 12 | 2010 | 83 | |
| 13 | 2020 | 78 | |
| 14 | 2013 | 76 | |
| 15 | 2007 | 73 | |
| 16 | 2010 | 63 | |
| 17 | 2007 | 60 | |
| 18 | 2007 | 57 | |
| 19 | 2019 | 55 | |
| 20 | 2009 | 53 |
About Kai Hilpert
Kai Hilpert is a scholar working on Molecular Biology, Microbiology, Immunology, Ecology and Organic Chemistry, having authored 71 papers that have together received 8.4k indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (48 papers), Biochemical and Structural Characterization (26 papers), Chemical Synthesis and Analysis (15 papers), Bacteriophages and microbial interactions (9 papers), Protein Hydrolysis and Bioactive Peptides (7 papers), Immune Response and Inflammation (6 papers), Enzyme Production and Characterization (6 papers) and Probiotics and Fermented Foods (6 papers). The work is most often cited by research in Microbiology (3.8k citations), Molecular Medicine (904 citations), Molecular Biology (4.3k citations), Food Science (1.1k citations) and Organic Chemistry (1.5k citations). Kai Hilpert has collaborated with scholars based in Germany, United Kingdom and Canada. Frequent co-authors include Robert E. W. Hancock, Irith Wiegand, Rudolf Volkmer, Dirk Winkler, Håvard Jenssen, Christopher D. Fjell, Artem Cherkasov, Ralf Mikut, Serge Ruden and Anne S. Ulrich. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, Antimicrobial Agents and Chemotherapy, Frontiers in Pharmacology, Nature Protocols and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.